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Abstract
Human platelets must be stored at 22‡C in blood banks, because of the well-known phenomenon of cold-induced
activation. When human platelets are chilled below room temperature, they undergo shape change and vesicle secretion that
resembles physiological agonist-mediated activation. The trigger for the cascade of events leading to platelet activation at
hypothermic temperatures is not known, although an increase in the internal calcium concentration ([Ca]i) due to passage of
the platelet membranes through their thermotropic phase transition has been proposed. We report here that the fluorescent
calcium-sensitive probe, Indo-1, has been used to estimate the internal calcium concentration of human platelets during a
reduction in temperature from 20‡C to 5‡C at a rate of 0.5‡C/min. An increase on the order of 100 nM was recorded. Almost
all of the increase in [Ca2]i occurs during the chilling process, as incubation of platelets for 1 h at low temperature did not
lead to a continued calcium concentration increase. The increase in [Ca2]i during chilling is likely to be due to more than a
single mechanism, but might include some release of the calcium stores from the dense tubule system. Loading platelets with
the calcium chelator BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,NP,NP-tetraacetic acid) dramatically reduced the increase
in [Ca2]i seen during chilling. Antifreeze glycoproteins (AFGPs) isolated from the blood serum of Antarctic fishes, which are
known to protect platelets from cold-induced activation, did not eliminate the rise in [Ca2]i during chilling, suggesting that
signaling mechanisms are likely to be involved in cold-induced activation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The phenomenon of cold-induced activation of hu-
man platelets has greatly frustrated e¡ective storage
of these cell fragments. During hypothermic storage,
platelets undergo shape change from discoid to
spherical with multiple ¢lopodia [1,2], and secretion
of K-granule contents [3], in a process that mimics
physiological platelet activation [4,5]. Such platelets
are compromised in hemostatic capability as eval-
uated by platelet life-span and bleeding time analysis
[6,7]. Because they must therefore be stored at room
temperature (22‡C), their storage in blood banks is
limited by regulation to 5 days, due primarily to the
high level of bacterial contamination associated with
storage at such high temperature (for review, see [8]).
Even with this restriction in shelf-life, however, septic
shock due to transfusion of contaminated platelet
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fractions continues to represent a serious threat [8,9].
Understanding the process of cold-induced activation
is clearly signi¢cant, therefore, and may lead to more
favorable platelet storage conditions.
The mechanism causing cold-induced activation is
not known, although it has recently been suggested
to accompany passage of platelets through a mem-
brane phase transition [10]. It has been proposed
[10,11] that a possible trigger for cold-induced acti-
vation might involve an increase in the intracellular
calcium concentration ([Ca2]i), which could then
initiate the platelet activation cascade, as has been
shown with the calcium ionophore A23187 [12^14].
This would be consistent with the results of Winokur
and Hartwig [11] who found that actin fragmentation
and subsequent nucleation, key steps in the platelet
shape-change process, occurred when platelets were
chilled from 37‡C to 4‡C, but that they required a
rise in [Ca2]i as they were blocked by the calcium
chelators Fura-2 and Quin-2.
It is not a simple matter to measure the [Ca2]i of
human platelets during chilling, however. Platelets
are extremely small cell fragments, with diameters
in the range of 1.0 Wm [11], making impalement by
a microelectrode unpractical. Further, the various
spectroscopic methods used to measure the calcium
concentration within cells all depend on the equili-
brium balance of some reaction involving free calci-
um ions [15,16], and therefore all are a¡ected by
temperature. The £uorescent calcium-sensitive
probes used most extensively to determine the
[Ca2]i of various cell types are no exception.
A detailed report of the e¡ect of temperature on
the calcium-sensitive dyes is beyond the scope of the
current article, and will be presented separately.
Brie£y, there are many aspects of the physical envi-
ronment that can a¡ect the £uorescence intensity of
a given £uorophore, including but not limited to
temperature, pH, viscosity, and level of oxygen
quenching [17]. These variables can a¡ect such prop-
erties as excited state lifetimes and rates of non-radi-
ative decay, among others. In addition, if the £uoro-
phore is a calcium chelator, as is the case for the
calcium sensitive dyes, there are other considerations
as well. The binding properties must be taken into
account, because the dissociation constant is also af-
fected by temperature, pH, and ionic strength
[15,18,19]. Clearly, this is an extremely complicated
issue. One approach to this problem would be to
separate, quantify, and subtract the contribution of
each of these e¡ects to the report of calcium by Indo-
1, the complexity of which would be virtually
prohibitive. An alternative approach would be to
demonstrate that the e¡ects of temperature on the
£uorophore itself cannot be responsible for any
experimentally obtained result. This method,
although not quantitative, can still give impor-
tant information regarding trends, and we
have used this approach to estimate the internal
calcium concentration of human platelets during
chilling.
The mechanism of cold-induced activation may be
more complex than a simple increase in the internal
calcium concentration, however. The possibility that
calcium is the trigger and only requirement for cold-
induced activation, can be tested using antifreeze gly-
coproteins (AFGPs) as a tool, because they have
been shown, by morphological assessment and £uo-
rescence activated cell scanning analysis, to inhibit
activation during storage of platelets for up to three
weeks at 5‡C [10]. These glycoproteins, isolated from
the blood serum of certain Antarctic ¢shes, consist of
the repeating triplet alanine^alanine^threonine, with
each threonine glycosylated by a galactose-N-acetyl-
galactosamine moiety [20]. In vivo, AFGPs lower the
freezing temperature of the serum in a non-colliga-
tive manner [20^22], but they have also been shown
in vitro to protect membranes and whole cells during
chilling at temperatures well above freezing [10,23,24]
(and for review, see [25,26]). For instance, AFGPs
prevent lipid vesicles composed of dielaidoylphos-
phatidylcholine (DEPC) from leaking during chilling
through their membrane phase transition (10‡C) [24].
Because AFGPs e¡ectively protect platelets from
cold-induced activation [10], they emerge as a means
by which to discriminate between di¡erent steps in
the activation cascade. Evidence will be presented
that although AFGPs are known to prevent cold-
induced activation in platelets, they do not inhibit
the rise in the internal calcium concentration. This
suggests that the rise in calcium is probably not sole-
ly responsible for cold-induced activation and raises
the possibility that signaling processes may also be
involved.
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2. Materials and methods
2.1. Isolation and washing of human platelets
Blood was drawn from healthy human volunteers
into acid citrate dextrose bu¡er (ACD) (56.7 mM
citric acid, 112 mM sodium citrate, 170 mM dex-
trose) using a large bore needle (#19) and without
vacuum assistance to ensure a low shear force during
the draw. Approximately 30 ml blood was drawn
into 3 ml ACD, and prostaglandin E-1 (PGE-1)
was added to this mixture (from a 1 mg/ml stock
solution in 100% ethanol) to a ¢nal concentration
of 10 Wg/ml. Platelet rich plasma (PRP) was pro-
duced by centrifuging the whole blood in a pre-
warmed Beckman GS-15R centrifuge using an S41-
80 variable bucket rotor at 325Ug for 14 min with
an acceleration setting of 1. At all times, platelets
were maintained between 30‡C and 37‡C and
handled only with polypropylene or siliconized glass
(coated with Sigmacote, Sigma Chemical Co., St.
Louis, MO) pipettes and polypropylene test tubes.
Unless otherwise indicated, bu¡ers, salts, and col-
umn chromatography materials were purchased
from Sigma.
Washed platelets were produced by gel ¢ltering the
PRP (5^7 ml) over a Sepharose 2B column (7U2 cm)
[27] rinsed thoroughly with bu¡er A (100 mM NaCl,
10 mM KCl, 10 mM ethylene glycol-bis(L-aminoeth-
yl ether)N,N,NP,NP-tetraacetic acid (EGTA), and
10 mM imidazole; pH 6.8) (imidazole and EGTA
from Research Organics, Cleveland, OH). Washed
platelets (7^9 ml) were then collected in bu¡er A
and again supplemented with PGE-1 to a ¢nal con-
centration of 10 Wg/ml. The washed platelets were
then counted on a T-890 Coulter cell counter (Mi-
ami, FL) and allowed to ‘rest’ at 37‡C for 15^30 min
before loading.
2.2. Loading platelets with Indo-1
The £uorescent calcium-sensitive probe Indo-1-
acetoxymethyl ester (Indo-1-AM) (Molecular Probes,
Eugene, OR) was purchased in 50-Wg aliquots, and
each aliquot was used for a single experiment. Dry
dimethyl sulfoxide (DMSO) was purchased in sealed
ampoules (Sigma), and each ampoule was also used
for a single experiment. A 3 mM stock solution of
Indo-1-AM was prepared in the dry DMSO. Indo-1-
AM stock solution (V5 Wl) was mixed well with
0.5 ml of warm bu¡er A with 10 Wg/ml PGE-1,
and this mixture was again warmed to 37‡C for
10 min before combining with the washed platelets.
The ¢nal loading solution consisted of 5^6 ml of
approximately 2U108 platelets/ml with 3 WM Indo-
1-AM and 10 Wg/ml PGE-1 in bu¡er A. This solution
was mixed by gentle pipetting and allowed to incu-
bate at 37‡C for 45 min. The AM form of the dye is
membrane permeable, but once inside the AM-ester
is cleaved by non-speci¢c esterases, resulting in the
calcium-sensitive form of the dye [19].
The Indo-1-loaded platelets were washed over a
Sepharose 2B column rinsed thoroughly with phos-
phate-bu¡ered saline (PBS) (9.4 mM Na2HPO4,
0.6 KH2PO4, 100 mM NaCl) supplemented with cal-
cium and magnesium (10 WM CaCl2, 10 WM MgCl2).
The loaded, washed platelets were again counted on
a Coulter cell counter showing a concentration of
approximately 1U108 platelets/ml. Calcium was
then added gradually to a ¢nal external calcium con-
centration of 1 mM, in ¢ve aliquots of Tyrodes wash
(148 mM NaCl, 2.5 mM KCl, 23 WM MgCl2, 5 mM
glucose with 10 mM CaCl2) at 5-min intervals, in
order to avoid shocking the platelets. The only ex-
ception to this procedure was the experiment done in
the absence of extracellular calcium. In this case, the
platelets were washed over a column using PBS with-
out added calcium and magnesium.
In the experiments involving the calcium chelator
1,2-bis(2-aminophenoxy)ethane-N,N,NP,NP-tetraace-
tic acid (BAPTA), a trace of the non-toxic detergent
pluronic was placed in a clean 1.5 ml microfuge tube
to which the Indo-1-AM (6 Wl of 3 mM) and
BAPTA-AM (3 Wl of 20 mM) stock solutions in
dry DMSO were added. This sample was centrifuged
at 10 000 rpm on a Microfuge-11 (Beckman, Palo
Alto, CA) for 2 min to ensure the pluronic and
DMSO were well mixed and subsequently warmed
to 37‡C for 10 min. A 0.5-ml aliquot of bu¡er A
with 10 Wg/ml PGE-1 was also warmed to 37‡C for
10 min and subsequently mixed well with the DMSO
stock solution mixture. Washed platelets (5.5 ml)
were combined with the DMSO/bu¡er solution giv-
ing ¢nal concentrations of 3 WM Indo-1-AM and
10 WM BAPTA-AM with approximately 2U108
platelets/ml in bu¡er A with 10 Wg/ml PGE-1. The
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solution was mixed gently by pipetting, and allowed
to incubate at 37‡C for 45 min. Removing the excess
Indo-1-AM and BAPTA-AM was accomplished by
column chromatography as described above.
2.3. Measurement of internal calcium concentration of
human platelets
The internal calcium concentration of the loaded
platelets was quanti¢ed using a Hitachi F-2000 £uor-
ometer controlled with a PC using the F-2000 IC
cation-measurement software (Hitachi). Unless
noted, platelets were measured at the ¢nal concen-
tration of 1U108 platelets/ml in PBS with 1 mM
CaCl2. Samples of 770 Wl were loaded into 1.0 ml
methacrylate UV/vis cuvettes (Fisher Scienti¢c, Pitts-
burgh, PA) and stirred using a small magnetic stir-
bar and built-in stir-plate. Samples were excited at
350 nm, and emission measured at 405 and 480 nm.
The internal calcium concentration during a partic-
ular experiment was calculated after the addition of
the detergent digitonin (5 mM in ethanol to a ¢nal
concentration of 0.25 mM; Aldrich Chemical Co.,
Milwaukee, WI) to give a maximal calcium value
and the calcium chelator EGTA (250 mM in 2.5 M
Tris base (tris[hydroxy-methyl]aminomethane) to a
¢nal concentration of 12 mM) to give a minimal
calcium value, using the Kd of 250 nM [19] except
where otherwise noted. The equation used to deter-
mine [Ca2]i was as follows:
C  KdUR3RminRmax3RU
FminV2
FmaxV2
At the beginning and end of each set of experi-
ments, platelets were tested for their responsiveness
to the agonist thrombin. After a baseline was col-
lected, thrombin was added (to a ¢nal concentration
of 1 U/ml) before the digitonin and EGTA additions.
Thrombin, digitonin, and EGTA were added by in-
jection with a Hamilton syringe directly to the cuv-
ette through the injection port.
2.4. Chilling human platelets
Two circulating water baths were connected by
insulated tubing to the jacketed cuvette holder and
separated from each other by valves. The heated
water bath was held at 42‡C, and the chilled water
bath was held at 35‡C. After a baseline was col-
lected at a sample temperature of 37‡C (V100 s),
the heated bath valve was closed and the chilled
bath valve was opened. The samples were cooled at
2‡C/min from 37‡C to 20‡C, then at 0.5‡C/min from
20‡C to 5‡C. When sample temperature reached 5‡C,
the process was reversed, and samples were heated to
37‡C at approximately 2‡C/min. Platelet samples
were then treated sequentially with thrombin, digito-
nin, and EGTA, and calcium concentration was cal-
culated as stated above.
2.5. Antifreeze glycoproteins from antarctic ¢shes
Antifreeze glycoproteins (AFGPs) isolated from
the blood serum of Trematomus bernachii and T.
borchgrevinki as previously described [21] were a gen-
erous gift of Dr. Robert E. Feeney. Pooled fractions
7 and 8 (T. bernachii) and fractions 3, 5P, 6 (T. borch-
grevinki) with molecular mass in the range of 2.6^
33.7 kDa were used at 1 mg/ml in chilling experi-
ments with Indo-loaded human platelets at a concen-
tration of 5U107 platelets/ml.
3. Results and discussion
3.1. Indo-1-loaded platelets are thrombin-responsive
It was important, as a ¢rst control, to show that
the Indo-1-loaded platelets were healthy and physio-
logically active. Fig. 1 shows the response of the
platelet internal calcium concentration ([Ca2]i) to
the physiological agonist thrombin. The top panel
(Fig. 1A) displays the raw £uorescence data in arbi-
trary £uorescence units (AFU), while the bottom
panel (Fig. 1B) shows the [Ca2]i, calculated as de-
scribed in Section 2. It is clear that the platelets ex-
hibited the well-known increase in [Ca2]i that is
consistent with normal platelet function [28^30] (for
review, see [31,32]).
Also shown in Fig. 1 are the maximal and minimal
calcium concentrations achieved by the additions of
digitonin and EGTA, respectively. It is not unusual
that the calcium concentration value seen after the
addition of digitonin does not match exactly the
known external calcium concentration (1 mM), be-
cause this concentration is so great in comparison to
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the Kd of Indo-1 (250 nM) that the calculation will
not be accurate in this range. The digitonin and
EGTA are added only to give maximal and minimal
values for the two Indo-1 emission wavelengths,
which are then used for calculation of the internal
calcium concentration.
As mentioned in Section 1, most £uorescent
probes are temperature-sensitive. Thus, another im-
portant control was to determine how temperature
a¡ected the report of calcium by Indo-1. Fig. 2
shows the results of such controls. The ¢rst type of
condition studied was a saturating calcium concen-
tration. Either platelets were chilled in the presence
of digitonin (Indo-1 is exposed to 1 mM Ca2), or
the pentapotassium salt of Indo-1 (1 WM in PBS) was
chilled in the presence of 1 mM Ca2. Although the
calculated values for the calcium concentration from
measurements in the presence of 1 mM Ca2 are not
accurate, it is still important to observe the e¡ect of
temperature on the reported calcium value. As the
dye will be continuously saturated at such a high
calcium concentration, the e¡ects of temperature on
Kd will be negligible, and the e¡ect of temperature on
£uorescence intensity will predominate. In both
cases, although there was a signi¢cant e¡ect of tem-
perature between 38‡C and 20‡C, there was very little
change in the reported calcium value between 20‡C
and 5‡C. The small change that was apparent be-
tween 20‡C and 12‡C actually showed a decrease in
the reported calcium value during chilling. This ef-
Fig. 1. Response of Indo-1-loaded platelets to 1 U/ml thrombin. (A) Fluorescence intensity traces for both emission wavelengths in ar-
bitrary £uorescence units (AFU). (B) Platelet intracellular calcium concentration. Thrombin, digitonin, and EGTA additions are indi-
cated by arrows. Tests for thrombin-responsiveness were performed at 35‡C.
BBAMEM 77542 4-1-99
A.E. Oliver et al. / Biochimica et Biophysica Acta 1416 (1999) 349^360 353
fect, as it is a change in the opposite direction from
what is observed in human platelets, could lead to an
underestimation in the elevation of [Ca2]i during
chilling.
The second type of condition studied was a low,
more physiologically relevant calcium concentration,
in the range of 0^500 nM. The simplest possible sys-
tem was constructed in order to focus speci¢cally on
the e¡ects of temperature on Indo-1, thus Indo-1
itself served as the only calcium bu¡er. Using
10 mM TES to bu¡er the pH to 7.2, 0.1 M KCl,
and 10 WM Indo salt, free calcium was adjusted to
V300 or V500 nM by the addition of CaCl2. The
approximate Kd of Indo-1 under these conditions
was estimated using the program MaxChelator [33]
to be 165 nM at 37‡C. Under these circumstances,
the e¡ect of temperature on Kd of the dye becomes
apparent. As temperature decreases, the dye reports
a small but consistent drop in free calcium between
38‡C and 5‡C, if the Indo-1 Kd is not adjusted for
temperature (see Fig. 2). This trend is important,
because it would be extremely di⁄cult to know the
exact conditions of pH, ionic strength, and viscosity
inside the platelets at each temperature in the series,
all of which a¡ect indicator Kd [15,18,19,34]. It
would, therefore, be next to impossible to have an
accurate Kd for Indo-1 in the internal environment of
the platelets at each temperature during chilling and
warming. This is an admittedly imperfect system, and
an exact measurement of the free calcium concentra-
tion inside human platelets during chilling is prob-
ably an unreasonable goal. Nevertheless, cold-in-
duced activation of platelets is such a critical issue
in the blood banking community, that evidence for
its mechanism, even if only an approximation and
not a quantitative measurement, would still be im-
portant information. Since the e¡ect of decreased
temperature on Indo-1 is a decrease in the reported
free calcium, any increase in free calcium seen in the
platelets during chilling would be a valid increase
and also an underestimate.
A third condition was also examined. EGTA
(1 mM) was included in the absence of added calci-
um. Indo-1 showed the same trend in this case, but
exhibited a smaller change in the reported calcium
value.
One additional set of controls was conducted to
ascertain if Indo-1 leaked out of the platelets during
the course of these experiments. Since there was
1 mM CaCl2 in the extracellular bu¡er, if Indo-1
leaked out of the cells, it would report an apparent
increase in [Ca2]i, even if [Ca2]i had not changed.
Platelets maintained at constant temperature (25‡C)
showed no change in the [Ca2]i during a 50-min
incubation (data not shown).
3.2. Intracellular calcium concentration increases in
human platelets during chilling
Chilling human platelets from 20‡C to 5‡C re-
sulted in an increase in [Ca2]i, as shown by a rep-
resentative experiment (Fig. 3). The raw £uorescence
data appear in Fig. 3A, and the calculated [Ca2]i
appears in Fig. 3B. It is clear that the [Ca2]i in-
Fig. 2. E¡ect of temperature on Indo-1 £uorescence under con-
ditions of di¡erent calcium concentrations. For a saturating cal-
cium concentration, platelets were either disrupted with digito-
nin, exposing the Indo-1 to 1 mM CaCl2 (F), or the
pentapotassium salt of Indo-1 (1 WM in PBS) was studied in
the presence of 1 mM CaCl2 (O). For non-saturating condi-
tions, a simpli¢ed system using Indo-1 as the only calcium bu¡-
er was used (10 WM Indo-1 salt, 0.1 M KCl, pH 7.2). The free
Ca2 concentration was adjusted to V300 (b) or V500 (a)
nM by the addition of CaCl2 as described in the text, or free
Ca2 was eliminated (1 mM EGTA) (E).
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creased by more than 100 nM during chilling. Again,
the magnitude of this increase is underestimated and
varied somewhat, depending presumably on di¡eren-
ces in donor platelet physiology as well as other fac-
tors.
The [Ca2]i then decreased during rewarming to
37‡C, which we suggest may be due to a variety of
factors. We will return to a discussion of the possible
mechanisms of the calcium changes below. However,
if this phenomenon were due to a simple e¡ect of
temperature on the dye, one would expect the oppo-
site pattern. That is, the Ca2 value would be ex-
pected to decrease during chilling and increase during
rewarming as can be seen with the Indo-1 salt in
solution (cf. Fig. 2).
3.3. Increase in [Ca2+]i occurs primarily during
chilling
In order to determine if the [Ca2]i continues to
increase if platelets are stored for short periods at
low temperature, Indo-loaded platelet samples were
chilled as usual to 5‡C, followed by a 1-h incubation
at this temperature. The results indicate that most of
the elevation in the [Ca2]i occurred during the chill-
ing process, as the [Ca2]i changed little during the
hypothermic incubation (Fig. 4). The platelets re-
mained viable after the 1-h period at 5‡C, however,
as the [Ca2]i decreased as usual during rewarming,
and the platelets were still thrombin-responsive (Fig.
4). The possibility remains, of course, that the [Ca2]i
Fig. 3. Temperature dependence of intracellular calcium concentration during chilling of human platelets from 20‡C to 5‡C at a rate
of 0.5‡C/min. (A) Fluorescence intensity traces for both emission wavelengths in AFU. (B) Platelet intracellular calcium concentration.
The initiation of chilling below 20‡C and rewarming, as well as thrombin, digitonin, and EGTA additions are indicated by arrows.
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might continue to increase during long-term hypo-
thermic storage. This scenario would be problematic
to test, however, as the £uorescent dye leaks out over
time and can be somewhat toxic to the cells [35],
making the di¡erentiation between the long-term ef-
fect of low temperature and the long-term e¡ect of
Indo-1 extremely di⁄cult.
3.4. Calcium increases in human platelets chilled
under various conditions
In order to show the progression of the [Ca2]i
increase during chilling, the change in [Ca2]i was
plotted as a function of temperature for human pla-
telet samples chilled under various circumstances
(Fig. 5A). A representative trace is shown for each
of three conditions, and the mean and standard de-
viation of the [Ca2]i increases for each condition are
Fig. 4. The change in intracellular calcium concentration of hu-
man platelets chilled from 37‡C to 20‡C at a rate of 2‡C/min,
then to 5‡C at 0.5‡C/min. The platelets were then incubated for
1 h at 5‡C and subsequently rewarmed to 37‡C at 2‡C/min.
Time points corresponding to the initiation of chilling and re-
warming, as well as the addition of thrombin, are indicated by
arrows. Two independent data sets are shown.
C
Fig. 5. A. The change in [Ca2]i of human platelets chilled to
5‡C at a rate of 0.5‡C/min under various conditions: control
(PBS, 1 mM Ca2) (a), no external Ca2 (F), Indo-1/BAPTA-
loaded platelets (8). All data points except those taken in the
presence of BAPTA were ¢t with a single curve (r2 = 0.96) with
TableCurve software (Jandel Scienti¢c, San Rafael, CA). Data
points taken in the presence of BAPTA were curve ¢t sepa-
rately (r2 = 0.99). (B) The relationship between the increase in
[Ca2]i during chilling and cold-induced activation in human
platelets. Temperature-speci¢c activation data were taken from
[10] and are based on morphological assessment. Brie£y, cells
were examined microscopically, and classi¢ed as resting based
on discoid morphology. Cells exhibiting spherical shape or hav-
ing one or more ¢lopodia were classi¢ed as activated. Data
points were taken from the respective curve ¢ts, in order to ob-
tain activation and calcium data for identical temperatures.
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given in Table 1. The striking result from this series
of experiments was that, there was very little di¡er-
ence between the [Ca2]i increase seen in control pla-
telet samples (external bu¡er solution = PBS+1 mM
Ca2) as compared to samples chilled in the absence
of extracellular Ca2 (external bu¡er solution = PBS,
tested for and showing no contamination with calci-
um). Platelets in this test group were never exposed
to high extracellular calcium. Their starting calcium
concentration and change over time at constant tem-
perature were similar to control samples. Statistical
(t-test) analysis revealed no signi¢cant di¡erence be-
tween this group and the control. This ¢nding sug-
gests that the [Ca2]i increase seen during the chilling
of platelets cannot be due to leakage across the plas-
ma membrane, and must be due to release from some
internal source. These results correlate well with pre-
vious data regarding cold-induced activation of pla-
telets, which is known to proceed when washed pla-
telets are stored in the absence of extracellular
calcium (10 mM EGTA) [10].
If the elevation of the [Ca2]i seen in Indo-1
loaded platelets chilled to 5‡C were a genuine e¡ect,
co-loading the cells with the non-£uorescent calcium
chelator BAPTA should be able to reduce it. Indeed,
as shown in Fig. 5A, when platelets co-loaded with
both Indo-1 and BAPTA were chilled to 5‡C, they
exhibited a dramatically reduced elevation in [Ca2]i
(t-test revealed signi¢cant di¡erence from controls at
P = 0.001). This result suggests that the increase in
[Ca2]i measured continuously during the chilling
of human platelets is a real e¡ect, as it can be mark-
edly diminished by introducing a calcium chelator
into the intracellular space. BAPTA itself does not
£uoresce at these wavelengths, as control experi-
ments showed no di¡erence between the £uorescence
intensities of a BAPTA salt solution in bu¡er and
bu¡er alone.
The correlation between cold-induced activation in
platelets and the intracellular calcium increase can be
evidenced by plotting degree of platelet activation
against v[Ca2]i (Fig. 5B). Cold-induced activation
was assessed morphologically (data from [10]) on
the basis of discoid (classi¢ed as resting) versus
spherical shape with one or more ¢lopodia (classi¢ed
as activated). This correlation between v[Ca2]i and
activation agrees well with a report showing that
platelets exposed to 4‡C underwent calcium-depend-
ent actin reorganization resulting in platelet shape
change [11].
3.5. Possible mechanisms
There are several mechanisms that may contribute
to the elevation in calcium seen in chilled platelets,
which the data suggest is released from some internal
store. The dense tubule system (DTS), which is the
calcium storage organelle in platelets [36^38], is one
logical source from which calcium could be released
by either active or passive leak processes. Four alter-
native, but not mutually exclusive mechanisms might
account for the temperature-dependent increase in
intracellular calcium.
3.5.1. Lipid phase transitions
A well-known property of membranes passing
through this transition is that they become transi-
ently leaky, which is thought to be due to the mis-
match of molecules at the interfaces between regions
of lipid in the gel and those in the liquid crystalline
state [24,39^43]. Therefore, passage of the DTS
membranes through their phase transition could re-
sult in a signi¢cant calcium leak and an increase in
the [Ca2]i. The membrane phase transition of intact
human platelets, as determined by Fourier transform
infrared spectroscopy, occurs between 20‡C and
Table 1
Increases in the [Ca2]i in human platelets chilled from 20 to 5‡C under various conditions
Sample n Mean v[Ca2]i (nM) S.D. t-Test
Control 8 113 34
No extracellular Ca2 5 92 23 NS
BAPTA (intracellular) 5 45 5 P = 0.001
+AFGP 7p8 4 108 38 NS
+AFGP 3,5P,6 5 91 16 NS
NS, no signi¢cant di¡erence from controls.
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10‡C [10], roughly the same temperature range in
which we see the elevation in [Ca2]i. However,
[Ca2]i continues to rise, as does platelet activation
[10] after the phase transition appears to be com-
plete, suggesting that other mechanisms are likely
to be involved.
3.5.2. Pump-leak imbalance
It is likely that the DTS permits passive leakage of
calcium at all temperatures, but that under physio-
logical conditions, this leak is compensated by active
calcium pumps [44^47], thus leading to a steady state
low concentration of calcium in the cytosol
[30,31,48]. It would not be unusual if the platelet
Ca2-pumps could not operate normally while the
samples were subjected to hypothermic conditions,
because membrane £uidity is reduced at low temper-
ature [17,49^51]. The physical state of the membrane
is an important determinant of activity for many in-
tegral membrane enzymes. In fact, a more rigid
membrane environment has been shown to decrease
the activity of Ca2-ATPases from skeletal muscle
sarcoplasmic reticulum [52], and erythrocyte plasma
membrane [53]. A similar dependence on membrane
£uidity has been shown for the Na,K-ATPase [54^
57]. At decreased temperatures, therefore, it would
be reasonable to expect that activity of the calcium
pumps would be depressed, leading to accumulation
of calcium in the cytosol.
3.5.3. Signaling mechanisms
It is well known that phospholipase A2 activity
depends heavily on the physical state of the mem-
brane and exhibits increased activity near the phase
transition, due to disruption of the membrane bilayer
[58,59]. There is some evidence that phospholipase C
(PLC) activity is also a¡ected by the physical state of
the bilayer [60,61]. If phospholipase C were activated
at the membrane phase transition in platelets, it
could initiate its signaling pathway, causing release
of calcium from internal stores by the production of
inositol 1,4,5-trisphosphate [62,63] (or for review, see
[64,65]).
3.5.4. Release of calcium from chelation sites
A fourth possibility is that various calcium-binding
molecules within the platelet could be a¡ected by
temperature in the same manner as are EGTA and
BAPTA, such that decreasing temperatures cause a
decrease in their calcium a⁄nity [18,33,66]. This
would result in a release of free calcium into the
internal milieu. Calcium released by this mechanism
would be likely to continue as temperatures dropped.
In any case, an increase in the free calcium concen-
tration, regardless of its origin, could a¡ect the acti-
vation state of human platelets [12^14].
The mechanisms causing the decrease in calcium
seen in the platelets during warming (e.g., Figs. 3 and
4) are likely to be complex as well. One possibility is
that any e¡ects that the decreased temperatures had
on the binding properties of internal calcium-binding
molecules would be reversed as the samples were
warmed. Free calcium released by this mechanism
would be removed by rebinding. Another possible
mechanism for the decrease in internal calcium dur-
ing warming would be active pumping. It is possible
that when the platelets are re-warmed, and normal
membrane £uidity restored, the Ca2-ATPase might
be again capable of pumping some of the calcium
back into the DTS or out of the cell through the
plasma membrane.
3.6. AFGPs do not prevent calcium increase in human
platelets during chilling
Since the physiological activation cascade in plate-
lets involves several di¡erent signaling pathways
[48,67^69], it is reasonable to hypothesize that signal-
ing mechanisms are also important in the process of
cold-induced activation. The AFGPs from polar ¢sh
provide a unique tool with which to investigate this
possibility, because they are known to inhibit cold-
induced shape change and secretion of K-granules in
platelets stored at 5‡C for up to 3 weeks [10]. The
AFGPs do not, however, inhibit the elevation of in-
tracellular calcium of platelets chilled to 5‡C (Fig. 6).
Platelets chilled in the presence of 1 mg/ml AFGP, a
concentration su⁄cient to protect platelets from
cold-induced activation during hypothermic storage,
showed the same magnitude of calcium increase as
control platelet samples. Statistical (t-test) analysis
revealed no signi¢cant di¡erence between the
AFGP and control samples. Representative traces
are shown in Fig. 6, and the mean and standard
deviation of the [Ca2]i increases for each condition
are given in Table 1. AFGPs must, therefore, inhibit
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some event in the platelet activation cascade either
downstream of the calcium increase, or along a sep-
arate pathway from calcium. It is possible that more
than one signal transduction pathway may be oper-
ating during chilling. Studies regarding the speci¢c
contribution of signal transduction to cold-induced
activation in platelets are currently underway, and
will be reported separately.
In summary, we demonstrate here that chilling hu-
man platelets to 5‡C results in an elevation of the
[Ca2]i that is likely to be released from some inter-
nal source. This study represents, to the authors’
knowledge, the ¢rst continuous measurement of the
[Ca2]i during the chilling of human platelets. The
elevation in the [Ca2]i probably contributes to
cold-induced activation of human platelets by initiat-
ing downstream events in the activation cascade.
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